Disclosed is a method for rejuvenating cells, such as chondrocytes, that involves contacting the cell with a composition comprising a synthetic ribonucleic acid comprising at least one modified nucleoside encoding a telomerase reverse transcriptase, and a composition comprising an anti-inflammatory agent, in amounts effective to extend at least one telomere in the cell.